Evidence map›Paper›PMID 39133201›Full record

ArticleClinical and translational medicine2024

Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice.

Emma J Sailor-Longsworth, Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Kristina Ly, Duane Currier, Taosheng Chen, Jian Zuo, Tal Teitz

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Emma J Sailor-LongsworthDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Richard D LutzeDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Matthew A IngersollDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Regina G KelmannDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Kristina LyDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Duane CurrierDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Taosheng ChenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jian ZuoDepartment of Biomedical Sciences, School of Medicine, Creighton University, Omaha, Nebraska, USA.
Tal TeitzDepartment of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska, USA.ORCID 0000-0001-7897-1630

Funding

Understanding the progression of hearing loss in an endolymphatic hydrops modelP20GM139762 · NIGMS · CREIGHTON UNIVERSITY · PI Hui Hong · 2021 to 2026
$16.1M
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing LossR01DC018850 · NIDCD · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI TEITZ, TAL · 2021 to 2025
$2.3M
American Hearing Research Foundation 2020Department of Defense LB 506Department of Defense RH200032Department of Defense #W81XWH-21-1-0696National Institutes of Health NIDCD 1R01DC018850Nebraska State, Department of Health and Human Services, Cancer and Smoking Disease Research ProgramNIDCD NIH HHS R01 DC018850NIGMS NIH HHS P20 GM139762
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHearing LossOseltamivirAnimalsDisease Models, AnimalMiceAntiviral AgentsOseltamivir

Identifiers

PMID39133201
PMCPMC11318337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.